GlassScriptPhysician profile
Piero Capecci
NPI 1154321222
$7,644.47
in general payments reported to CMS, 2019-2025
8 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $131 · 2021: $561 · 2022: $516 · 2023: $658 · 2024: $3,204 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,818 · Food and Beverage: $2,473 · Education: $86.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,817.89 |
| Food and Beverage | $2,472.72 |
| Education | $86.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,789.90 | 2019-2025 | Persona, Avenir |
| Depuy Synthes Sales INC. | $2,370.92 | 2019-2025 | Emphasys, Na, Velys |
| Orthalign INC | $280.26 | 2023 | Orthalign Plus |
| Smith+Nephew, INC. | $113.49 | 2019-2025 | Pico 14, Pico 7 |
| Ferring Pharmaceuticals INC. | $33.19 | 2020-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $21.27 | 2025 | |
| Fidia Pharma USA INC. | $20.97 | 2025 | Hymovis |
| Pacira Therapeutics, INC. | $14.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piero Capecci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.